MarketLens
Sign Up

Saba Capital's ECAT Sales: A Calculated Gambit in a Protracted Proxy War

2 months ago
SHARE THIS ON:

Saba Capital's ECAT Sales: A Calculated Gambit in a Protracted Proxy War

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

News1 week ago

Strive: Capitalizing On An Early Bitcoin Cycle Shift With Downside Protection

Strive's ASST surged to 1.69x mNAV, likely on a short squeeze, versus MSTR at 1.00x mNAV. ASST offers daily dividends and downside protection but limits upside; preferred SATA yields ~13% annually wit...
Stock News2 weeks ago

Your Active ETF Manager Lost Again, and 87% of Them Have Been Losing for a Decade

Active ETF managers underperformed again, with 87% losing to benchmarks over a decade, raising doubts about their value proposition and the industry's marketing of these funds.
Crypto News1 months ago

Grayscale's 0.15% Ethereum Mini Trust Fee Turns ETF Competition Into A Price Fight

Grayscale set a 0.15% sponsor fee for its Ethereum Mini Trust, intensifying the fee war among Ethereum ETF issuers and pressuring rivals to compete on price.

Breaking News

View All →

Top Headlines

View More →
Stock News29 minutes ago

Tesla Cybercabs Hit Austin Streets in Expansion of Robotaxi Service

Stock News34 minutes ago

Snowflake (SNOW) Stock Soars 16% After Q2 Earnings: Is It Still a Buy?

Stock News53 minutes ago

AI Infrastructure Demand Remains Red-Hot: HPE, AVGO, DELL Deliver

Stock News56 minutes ago

Nvidia: The Market Will Come To Its Senses Eventually

Stock News59 minutes ago

Why Microsoft Stock Is Up Today